VTVT: vTv Therapeutics, Inc. Company Short-Term Debt

Symbol and logo of brand vTv Therapeutics Inc (VTVT)

vTv Therapeutics Inc. develops unique drugs to combat Alzheimer's disease and diabetes by activating cellular defense. A team of top-tier biochemists operates in an agile environment, incentivized by RSU programs. The company's environmental profile is limited to compliance with laboratory disposal regulations. The short-term debt trend reflects liquidity dynamics, where 0.00 represents the latest metric reading.

VTVT (vtvtherapeutics.com) Company Short-Term Debts history from 07/04/2022 to 11/01/2026

VTVT (vTv Therapeutics, Inc.): analytical breakdowns and indicator data

- current quotes and average value forecast:
Price Chart vTv Therapeutics Inc|VTVT - Fair Value Consensus
- market capitalization information:
Market Value vTv Therapeutics Inc.|VTVT - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share vTv Therapeutics|VTVT - Book Capitalization|Market Cap to Net Assets Ratio vtvtherapeutics.com|VTVT - Aggregate Asset Value
- debt and liquidity data:
Debt to Equity vTv Therapeutics Inc.|VTVT - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital vTv Therapeutics Inc|VTVT - Company Cumulative Debt|Debt to Book Value vTv Therapeutics Inc.|VTVT - Amount of Long-Term Liabilities|Company Short-Term Debts vTv Therapeutics|Quick Ratio vtvtherapeutics.com
- net income and valuation multiples indicators:
VTVT - Company Net Income
Basic company analysis:vtvtherapeutics.com - VTVT
Mass-produced product of vTv Therapeutics, Inc.

Short-term debt measures the volume of obligations with a maturity of up to one year, allowing an investor to assess liquidity and the issuer's dependence on external funding. By analyzing the history of short-term liabilities on GURU.Markets, one can filter out market noise and determine whether vTv Therapeutics Inc. (VTVT) has sufficient resources to fund clinical trials of oral drugs before receiving royalties and insurance payments.

Who vTv Therapeutics Inc. competes with

ASND - Company Short-Term Debt|Company Short-Term Loans and Borrowings MDGL (Madrigal Pharmaceuticals Inc)|Corcept (CORT) - Company Short-Term Debt|Company Current Liabilities Rhythm Corp|AKRO (Akero Therapeutics) - Company Short-Term Debts|Company Short-Term Debts metsera.com|Company Current Liabilities MLTX (MoonLake)|CRNX (Crinetics Pharmaceuticals, Inc.) - Company Short-Term Loans and Borrowings|Company Short-Term Debt NewAmsterdam Pharma N.V. NAMS|SLNO - Company Current Liabilities|Amicus Therapeutics - Company Short-Term Debts|Short-Term Debt 89bio.com|AGIO (Agios Pharmaceuticals, Inc.) - Company Current Liabilities|GPCR: Amount of Current Liabilities|MDXG (MiMedx Group) - Company Short-Term Debts|Company Short-Term Debts Rezolute Bio|Company Short-Term Debts LXRX|Company Short-Term Debt MBX (mbxbio.com)|Company Short-Term Debt Altimmune ALT|Aardvark Therapeutics Inc. (AARD) - Short-Term Debt|SGMT - Company Short-Term Debt|BIOA: Company Short-Term Debt|BMEA: Company Short-Term Debts|QNCX - Short-Term Debt Volume|Company Short-Term Debt Fractyl Health|Agape ATP Corp. (ATPC) - Short-Term Debt Volume|Company Short-Term Debt Pluri Inc. (PLUR)|Company Current Liabilities synlogictx.com SYBX|Lipocine Inc. - Company Current Liabilities|Matinas BioPharma Holdings, Inc. - Company Short-Term Debt|SPRB: Company Current Liabilities|Galecto Inc - Amount of Current Liabilities|CTCX (Carmell Corp) - Company Current Liabilities|LUMO (Lumos Therapeutics) - Company Short-Term Debt|Company Current Liabilities ONVO|RDUS: Company Short-Term Loans and Borrowings